Serina Therapeutics, Inc. Annual Depreciation in USD from 2017 to 2020

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Serina Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2017 to 2020.
  • Serina Therapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $24K, a 33.3% increase year-over-year.
  • Serina Therapeutics, Inc. annual Depreciation for 2020 was $699K, a 668% increase from 2019.
  • Serina Therapeutics, Inc. annual Depreciation for 2019 was $91K, a 56.9% increase from 2018.
  • Serina Therapeutics, Inc. annual Depreciation for 2018 was $58K, a 64.8% decline from 2017.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2020 $699K +$608K +668% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2019 $91K +$33K +56.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $58K -$107K -64.8% Jan 1, 2018 Dec 31, 2018 10-K/A 2020-03-31
2017 $165K Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.